BALB/cJ and C57BL/6J Mice to Support Different Infection Models N32398NOI
Summary
AI-generated · Jun 13, 2026Provide a continuous, flexible supply of up to 5,160 specific-pathogen-free female mice in two strains (BALB/cJ and C57BL/6J), aged about 49–56 days and weighing 12–16 g. Delivery will be on an indefinite-delivery basis to support roughly 43 in vivo experiments over the upcoming year. The mice must be procured from the exact sources used in ongoing studies (CRL BALB/cJ and JAX C57BL/6J) to maintain consistent baselines; sourcing from other breeders is not acceptable due to potential phenotypic/genotypic variation that could invalidate historical data.
This is a single-source Blanket Purchase Agreement under FAR 13.106-1(b)(1). Firms that believe they can meet these requirements without introducing variation may submit a Capability Statement showing: (1) the ability to provide the exact genetic strains, (2) approval by Walter Reed Army Institute of Research, and (3) confirmation of SPF and antimicrobial-free guarantees. Submissions should be directed to the contracting officer by the stated deadline.
Description: The Combat Wound Infections Division (CWID) at Naval Medical Research Command (NMRC), intends to award a Blanket Purchase Agreement (BPA) to Charles River Laboratories (CRL) and The Jackson Laboratory (JAX) under the authority of FAR 13.106-1(b)(1), Soliciting from a Single Source for purchases not exceeding the Simplified Acquisition Threshold (SAT).The Naval Medical Research Command (NMRC) requires a continuous, flexible supply of up to 5,160 specific-pathogen-free (SPF) laboratory research mice. The requirement consists of female BALB/cJ and C57BL/6J strains, aged 49 56 days, and weighing 12 16 grams. The vendor must guarantee that all models are free from infectious diseases and have not received any prior systemic or topical antimicrobials. Delivery is required on a indefinite-delivery basis to support approximately forty-three (43) in vivo experiments scheduled between August 2026 and August 2027. Because CRL and JAX are approved by Walter Reed Army Institute of Research and planned studies are continuations of ongoing research, study baselines and control determinations have already been established using CRL BALB/cJ and JAX C57BL/6J mice, it is critical to ensure the animals are procured from these exact sources. Sourcing from alternative breeders would introduce unacceptable phenotypic and genotypic variation into the upcoming studies, which would invalidate historical data and jeopardize the integrity of the research. This notice of intent is not a request for competitive proposals. However, any firm that believes it can meet this requirement without introducing the aforementioned phenotypic/genotypic variation to the established baselines may submit a written Capability Statement. Responses must include: Evidence of the ability to provide the exact genetic strains (BALB/cJ C57BL/6J). Evidence that they have been approved by Walter Reed Army Institute of Research. Confirmation of the ability to meet the SPF and antimicrobial-free guarantees. Responses must be submitted to the Contracting Officer at priscilla.v.harrison.civ@health.mil no later than June 19, 2026. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government.
From Special Notice posted on Jun 12, 2026Notice history
1-
Special Notice LATEST Posted Jun 12, 2026
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA